Danaher Corporation (DHR)

Return on total capital

Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 4,498,000 4,446,000 4,367,000 4,789,000 4,924,000 4,865,000 5,018,000 5,329,000 5,582,000 6,225,000 6,981,000 7,642,000 8,206,000 8,388,000 7,865,000 7,851,000 7,839,000 7,311,000 6,958,200 6,150,700
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 52,534,000 51,071,000 52,334,000 50,849,000 49,543,000 51,299,000 49,897,000 53,442,000 53,486,000 52,407,000 51,716,000 51,478,000 50,082,000 46,985,000 46,594,000 46,356,000 45,167,000 43,451,000 42,756,000 40,419,000
Return on total capital 8.56% 8.71% 8.34% 9.42% 9.94% 9.48% 10.06% 9.97% 10.44% 11.88% 13.50% 14.85% 16.39% 17.85% 16.88% 16.94% 17.36% 16.83% 16.27% 15.22%

December 31, 2025 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $4,498,000K ÷ ($—K + $52,534,000K)
= 8.56%


Peer comparison

Dec 31, 2025

Company name
Symbol
Return on total capital
Danaher Corporation
DHR
8.56%
Agilent Technologies Inc
A
22.95%
Thermo Fisher Scientific Inc
TMO
15.94%